Australia Facial Injectable Market Size Worth $17.36 Billion By 2032 | CAGR: 24.3%

The global Australia facial injectable market size is expected to reach USD 17.36 billion by 2032, according to a new study by Polaris Market Research. The report “Australia Facial Injectables Market Share, Size, Trends, Industry Analysis Report, By Procedure Type, By Application (Aesthetics, Therapeutics), And Segment Forecasts, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis of future market growth.

Dermatologists and other professionals can address diverse facial areas, tailor treatments for individual patients, and employ a combination of products to achieve enhanced results. Millennials' choices in purchasing are notably swayed by peer recommendations, with a considerable influence stemming from social media. According to the 2020 Yellow Social Media Report, 63% of Australians indicated that endorsements from celebrities or social media influencers negatively impact their likelihood of making a purchase, whereas 15% reported the opposite effect.

Facial injectables find application in diminishing wrinkles and fine lines, adding volume and contouring, and establishing facial framework and structure. The anticipated growth in the industry is expected to be propelled by an increasing awareness of cosmetic procedures and the growing elderly population. Furthermore, advancements in facial rejuvenation and the shift in trends from invasive to minimally invasive procedures are additional factors foreseen to drive market growth.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/australia-facial-injectable-market/request-for-sample

Dermal fillers, often containing substances like hyaluronic acid, are utilized to restore volume, smooth out wrinkles, and enhance facial contours. They can be particularly effective in addressing issues like hyperpigmentation by providing a rejuvenated and even skin tone. Neuromodulators, such as botulinum toxin, are employed to temporarily relax muscles, reducing the appearance of fine lines and wrinkles. This not only helps in preventing the formation of new lines but also addresses early signs of aging, contributing to a more youthful appearance. The rising demand for facial injectables reflects a broader cultural shift towards non-invasive and non-surgical cosmetic procedures, driven by a desire for effective anti-aging solutions with minimal downtime. This trend underscores the integral role that facial injectables play in the contemporary landscape of aesthetic enhancement.

The surge in internet consultations was a notable outcome of the COVID-19 outbreak. Australia implemented a comprehensive temporary shutdown of beauty and cosmetic services as a preventive measure against COVID-19. The Centre for Mental Health at Swinburne University has been engaged in researching the impact of the beauty business closure on the mental health of Australians. The study revealed that, in comparison to the period before COVID-19, the general population expressed reduced interest in undergoing cosmetic surgery or treatments following the conclusion of the initial lockdown. This shift in interest subsequently affected the demand for facial injectables.

Australia Facial Injectables Market Report Highlights

• Botulinum type A segment held the largest revenue share, owing to its high success rate and increasing concerns among people to look young
• The hyaluronic acid segment will grow significantly, owing to its ability to recede down the epidermis and moisturize skin glands
• The therapeutics segment will grow rapidly, primarily due to a rise in non-invasive aesthetic procedures and innovations in drug formulations
• The market players include SILK Laser Clinics, Results Laser Clinic, Australian Skin Clinics, Advanced Clinics Australia, and Laser Clinics Australia

Polaris Market Research has segmented the Australia facial injectables market report based on procedure type, application, and region:

Australia Facial Injectables, Procedure Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Collagen
• Hyaluronic Acid (HA)
• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Polymer Fillers
  • Polymethylmethacrylate Microspheres (PMMA)
  • PLLA (Poly-L-lactic acid)

Australia Facial Injectables, Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Aesthetics
• Therapeutics

Australia Facial Injectables Market Report Scope